SLSN — Solesence, Inc. Common Stock

Summary of Solesence (SLSN) Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 Revenue: $12.5 million, stable compared to Q4 2024.
• Q4 Gross Profit: $3.4 million, up from $2.8 million in Q4 2024; Gross Margin improved to 27% from 22%.
• Operating Expenses: Increased to $3.2 million from $2.8 million in Q4 2024, impacted by facility consolidation costs.
• Net Income: $163,000, a turnaround from a net loss of $558,000 in Q4 2024.
• Full Year 2025 Revenue: $62.1 million, an 18.6% increase from $51.9 million in 2024.
• Full Year Gross Profit: $16.1 million, slightly down from $16.2 million in 2024.
• Adjusted EBITDA: $4.2 million, less than 7% of revenue.

2. Strategic Updates and Business Highlights

• Transform and Transcend Initiative: Launched to enhance operational efficiency and profitability, focusing on four pillars: operational excellence, technology-driven expansion, improved product development, and collaborative globalization.
• New Product Launch: Introduced Day Mode Hero Concealer, a hybrid product combining skincare and cosmetics, recognized in multiple award categories.
• Patent Portfolio: Increased by 20%, now totaling over 120 patents, enhancing market position and innovation leverage.
• Facility Consolidation: Successfully transitioned from three facilities to two without impacting on-time delivery performance.

3. Forward Guidance and Outlook

• 2026 Guidance: Targeting a gross margin floor of 30% and expecting EBITDA to return to double digits.
• Operational Focus: Emphasis on improving free cash flow and reducing safety stock to enhance operational health.
• Revenue Normalization: Anticipated in Q1 2026 due to customer order pattern changes and weak sell-through from a major mass market customer.

4. Bad News, Challenges, or Points of Concern

• Operational Inefficiencies: Transition costs and manufacturing inefficiencies from facility consolidation affected margins and profitability.
• Labor Costs: Elevated costs due to process changeovers and downtime impacted gross margins.
• Inventory Control Issues: Yield volatility and associated losses were significant headwinds to margins.
• Customer Dynamics: Noted challenges with sell-through from a large mass market customer, raising concerns about future revenue stability.

5. Notable Q&A Insights

• EPS Guidance: Management did not provide specific EPS targets for 2026, focusing instead on EBITDA improvements.
• Gross Margin Projections: A conservative approach was taken with a 30% gross margin floor, with aspirations for higher margins in the future.
• Production Challenges: Acknowledged ongoing struggles with production efficiency, attributed to rapid growth and new capability installations.
• Brand Partner Status: Clarified that there was no loss of a brand partner, but acknowledged challenges with sell-through from one partner.
• Investor Communication: Plans for improved investor communication and dedicated calls were mentioned to enhance transparency.

This summary encapsulates the key financial metrics, strategic initiatives, forward-looking guidance, and challenges faced by Solesence, providing a balanced view of the company's current status and future direction.